Interferon receptor alpha/beta is associated with improved survival after adjuvant therapy in resected pancreatic cancer

HPB

Volumn 9, Issue 4, 2007, Pages 289-294

  Saidi, Reza F ^a   Remine, Stephen G ^a   Jacobs, Michael J ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

Adjuvant therapy; Interferon; Interferon receptor; Pancreatic cancer

Indexed keywords

ALPHA INTERFERON RECEPTOR; ANTINEOPLASTIC AGENT; BETA INTERFERON RECEPTOR; FLUOROURACIL; INTERFERON RECEPTOR;

ADJUVANT THERAPY; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS RESECTION; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 34547929638     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820701329241     Document Type: Article

References (24)

1. Jemal, A., Siegel, R., Ward, E., Murray, T. and Smigal, C. (2006) Cancer statistics, 2006. CA Cancer J Clin, 56, pp. 106-130.
2. Warshaw, AL and Castillo, C Fernandez-del (1992) Pancreatic carcinoma. N Engl J Med, 326, pp. 455-465.
3. Ahrendt, SA and Pitt, HA (2002) Surgical management of pancreatic cancer. Oncology, 16, pp. 725-734.
4. Saidi, RF, Williams, F., Danquah, G., Mittal, VK and ReMine, SG (2006) Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines. Am J Surg, 191, pp. 358-363.
5. Saidi, RF, Williams, F., Silberberg, B., ReMine, SG and Jacobs, MJ (2006) Expression of interferon receptors in pancreatic cancer: identification of a novel prognostic factor. Surgery, 139, pp. 743-748.
6. Stark, GR, Kerr, IM, Williams, BR, Silverman, RH and Schreiber, RD (1998) How cells respond to interferons. Annu Rev Biochem, 67, pp. 227-264.
7. Der, SD, Zhou, A., Williams, BR and Silverman, RH (1998) Identification of genes differentially regulated by interferon β{PRIVATE "TYPE = PICT;ALT={alpha}"} or {PRIVATE "TYPE = PICT;ALT= {gamma}"}using oligonucleotide arrays. Proc Natl Acad Sci U S A, 95, pp. 15623-15628.
8. de Veer, MJ, Holko, M., Frevel, M., Walker, E., Der, S. and Paranjape, JM (2001) Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol, 69, pp. 912-920.
9. Kaplan, DH, Shankaran, V., Dighe, AS, Stockert, E., Aguet, M. and Old, LJ (1998) Demonstration of an interferon {PRIVATE "TYPE = PICT;ALT= {gamma}"}-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A, 95, pp. 7556-7561.
10. Afsari, A., Zhou, Z., Young, S., Ferguson, L., Sumet, S. and Mittal, V. (2002) Outcome analysis of pancreaticoduodenectomy at a community hospital. Am Surg, 68, pp. 281-285.
11. Jacobs, M., Mittal, V., ReMine, S. and Young, S. (2004) Defining the role of adjuvant therapy for adenocarcinoma of the pancreas. Curr Surg, 61, pp. 125-130.
12. Brembeck, FH, Schoppmeyer, K., Leupold, U., Gornistu, C., Keim, V. and Mossner, J. (1998) A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma. Cancer, 83, pp. 2317-2323.
13. Moore Jr, DF, Pazdur, R., Sugarman, S., Jones, D 3rd, Lippman, SM and Bready, B. (1995) Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma. Am J Clin Oncol, 18, pp. 525-527.
14. Macdonald, JS, Jacobson, JL, Modiano, M., Moore, DF, Gandara, DR and Schroder, LE (2000) A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: A Southwest Oncology Group study (SWOG 9413). Invest New Drugs, 18, pp. 269-273.
15. Bernhard, H., Jager-Arand, E., Bernhard, G., Heike, M., Klein, O. and Riemann, JF (1995) Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: Results of a phase II trial. Br J Cancer, 71, pp. 102-105.
16. Sparano, JA, Lipsitz, S., Wadler, S., Hansen, R., Bushunow, PW and Kirkwood, J. (1996) Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292. Am J Clin Oncol, 19, pp. 546-551.
17. John, WJ and Flett, MQ (1998) Continuous venous infusion 5-fluorouracil and interferon-alpha in pancreatic carcinoma. Am J Clin Oncol, 21, pp. 147-150.
18. David, AK, Vaughn, DJ, Holroyde, CP, Armstead, B. and Haller, DG (2000) A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: A Penn Cancer Clinical Trials Group (PCCTG) trial. Am J Clin Oncol, 23, pp. 37-39.
19. Wagener, DJ, Wils, JA, Kok, TC, Planting, A., Couvreur, ML and Baron, B. (2002) Results of a randomized phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: An EORTC gastrointestinal tract cancer group trial. Eur J Cancer, 38, pp. 648-653.
20. Picozzi, VJ, Kozarek, RA and Traverso, LW (2003) Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg, 185, pp. 476-480.
21. Picozzi, VJ and Traverso, LW (2004) The Virginia Mason approach to localized pancreatic cancer. Surg Oncol Clin N Am, 13, pp. 663-674.
22. Neoptolemos, JP, Cunningham, D., Friess, H., Bassi, C., Stocken, DD and Tait, DM (2003) Adjuvant therapy in pancreatic cancer: Historical and current perspectives. Ann Oncol, 14, pp. 675-692.
23. Kalser, MH and Ellenberg, SS (1985) Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg, 120, pp. 899-903.
24. Neoptolemos, JP, Stocken, DD, Friess, H., Bassi, C., Dunn, JA and Hickey, H. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 350, pp. 1200-1210.